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Abstract
Today, infertility has become a global issue. WHO ranks it the fifth among the major diseases of those below 60 years, after 
alcoholism, depression, injuries and eyesight disorders. Numerous studies conducted on the problems of infertility in endometriosis 
still do not offer clear answers regarding the pathogenesis and mechanisms of this disease and its influences on fertility.
According to the survey results, point mutations of the NAT2 gene (NAT2*5 and NAT2*6) have been identified in 75.6% of 
the patients with infertility problems and the peritoneal form of endometriosis, that create “slow” allelic variants, which exceed 
the average index in the population.
The peculiarities of the NAT2 gene polymorphisms have been proven to be associated with the effectiveness of the infertility 
treatment of female patients with peritoneal endometriosis. In the group of non-pregnant patients, the presence of с.341Т>C, 
c.481C>T, c.590G>A and c.803A>G  heterozygous point mutations are 73.2, 73.2, 5.4, and 62.5%, respectively. The significant 
difference in the comparison of the allelic polymorphism during the various stages of the endometriosis was not identified. At stage 
III-IV endometriosis the frequency of three and more point substitutions was significantly higher.
NAT2 gene polymorphisms can find use as an additional criterion for predicting the effectiveness of the infertility treatment 
of patients with peritoneal endometriosis. 
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Introduction
Currently, infertility is a global issue. WHO ranks it fifth 
among the major diseases of those below 60 years of age, after 
alcoholism, depression, injuries and eyesight disorders. The 
cold temperatures in most regions of the Russian Federation, 
early sexual debut, the high frequency of sexually transmitted 
infections and the low degree of contraceptive use result 
in the highest abortion rate in Europe, greatly reducing the 
reproductive potential of Russia to critically low numbers. 
Unfortunately, the present frequency of gynecological 
diseases shows no likelihood of decreasing and the frequency 
of  infertile  marriages  in  Russia  is  currently  above  15%. 
According to WHO, the total fertility rate in recent years is 
fast approaching the critical value of 1.3 (World’s Health 
Statistics, World’s Health Organization, 2011).
Despite the fact that in 30-40% of cases endometriosis 
is coupled with infertility, a clear understanding of the 
pathogenesis and mechanisms of the influence of this disease 
on fertility still remains elusive. Over the recent years, the 
roles  played  by  inflammation,  angiogenesis  and  oxidative 
stress were thoroughly studied by many Russian researchers 
[1].
The manifestation rate of endometriosis is known to 
affect the growth of the follicles and oocytes, embryo quality 
and the beginning of the pregnancy in ART [2]. According to 
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the classification of the American Fertility Society, patients 
at  stages  III-IV  endometriosis  show  significant  reduction 
in the ovarian reserve [3]. Foreign research studies have 
proven the presence of genetic polymorphism in the cases of 
endometriosis [4], polycystic ovaries, uterine fibroids, ovarian 
cancer, cervical cancer, premature ovarian failure, habitual 
miscarriage and preeclampsia [5,6]. Of great significance, the 
specific polymorphism observed in endometriosis from the 
standpoint of evidence-based medicine is the disorder of the 
gene system noted in the second detoxification phase [7].
According  to  the  specialized  literature,  the  presence 
of specific point mutations of the NAT2 gene is associated 
with widespread stages of endometriosis and extragenital 
endometriosis [8]. No other studies have been reported 
examining the correlation between the occurrence of the 
NAT2 gene polymorphism in endometriosis and infertility. 
The need to improve the diagnosis of the causes for infertility 
that accompanies peritoneal endometriosis became the basis 
for this study.
Materials and Methods
The  present  study  included  90  female  patients  with 
infertility  and  peritoneal  endometriosis,  verified  during 
laparoscopy. Laparoscopy was conducted at a clinical site 
of the Chair of Obstetrics, Gynecology and Reproductive 
Medicine of Advanced Training Faculty for health workers 
at Peoples’ Friendship University of Russia and at the 
Department of Reconstructive and Emergency Gynecology of 
the City Clinical Hospital #79 (Moscow).
Inclusion criteria:
1. Patients with peritoneal infertility and endometriosis, 
verified during laparoscopy
2. Between 20 and 43 years of age
Elimination criteria:
1. Patients with uterine fibroids and ovarian tumors
2. Patients with malformations of female genital 
mutilation
3. Male factor infertility
During the study, the patients were segregated into two 
groups depending on the effectiveness of the treatment: Group 
1 included 34 (37.8%) patients, who became pregnant on their 
own within 2-24 months after the surgery and Group 2, which 
had 56 (62.2%) patients, who failed to become pregnant during 
the same period of time. After evaluating the long-term results 
(uterine pregnancy occurring within 1-2 years), a comparative 
analysis of the results of the polymorphism of the NAT2 gene 
study in both women groups was conducted.
Laparoscopy was performed under standard conditions, 
using the traditional methods and employing the Karl Storz 
equipment. Surgeries were performed under endotracheal 
anesthesia. All patients underwent the standard preoperative 
examination. Contraindications to surgery were not identified. 
During the surgery the excision or coagulation of endometriosis 
was performed using different energy types (bipolar, argon 
plasma, laser).
Genetic research on the presence of polymorphism in 
the NAT2 genes was conducted in the Department of Genetics 
of  the  Federal  State  Institution  ‘N.F.  Gamaleya  Scientific-
Research Institute of Epidemiology and Microbiology’ of the 
Ministry of Health and Social Development of the Russian 
Federation. Informed consent for the use of blood for research 
was obtained from all the patients.
DNA samples isolated from the peripheral blood 
leukocytes of the patients served as the study material. 1 ml 
of 0.5M EDTA, pH 8.0 was used as the preservative. The 
first step was DNA extraction employing a set of reagents 
for the DLAtomтм DNA Prep100  isolation  according  to 
manufacturer’s protocol. To 200μl of blood in a 1.5ml test 
tube, 800μl of lysis reagent was added and all the test tube 
contents were thoroughly mixed by inverting it (5-10 times). 
Using a thermostat the test tube with the mixture was kept 
aside for 5-7 min at 65°C. Next, the test tube with the mixture 
was centrifuged for 10 seconds at 5000g, after which the clear 
supernatant was transferred to a clean test tube. A suspension 
of 30-40μl of the sorbent NucleoS™ was then added. The test 
tube was then placed on a rotator and mixed for 10 min and 
centrifuged again for 10 seconds at 5000g. The supernatant 
was removed without unsettling the sediment. Next, 400μl 
of lysis reagent was added to the sediment and vortexed 
thoroughly to reach a completely homogeneous state. Then, 
1 ml of saline buffer and the test tube contents were added to 
this test tube and then shaken well 5-10 times, before being 
centrifuged  for  10  seconds  at  5000g. The  supernatant  was 
removed without disturbing the sediment. Saline buffer 1 ml 
was added to the test tube and the entire contents were mixed 
together and centrifuged once more for 10 seconds at 5000g, 
after which the supernatant was carefully removed. The whole 
process was repeated 12 times. Next, the sediment was dried 
at a temperature of 65°C for 4-5 min. After this, 100-200μl of 
bi-distilled water or ExtraGene was added into the same test 
tube. Next, the content of the tube was suspended on a vortex 
for 5-10 sec to obtain a homogenous suspension. After that, 
it was thermostated for 5-10 seconds at 65°C. Once again, 
it was suspended and centrifuged for 2 minutes at 10000g. 
The supernatant with the DNA was transferred into a clean 
test tube and stored at t = -20°C. Next, the amplification of 
all the tested DNA fragments using the PCR method in 25ml 
volume of reaction mixture was performed. The concentration 
of MgCl2 in 1 x reaction buffer and annealing temperature 
were individually selected. The PCR was performed on a 
programmable thermal cycler MC2 manufactured by the DNA 
technology company with the following parameters:
 Initial denaturation at 95°C for 5 minutes 
                                      940С - 45 seconds 
            28-30  cycles                  t, 0С - 45 seconds 
                                      720С - 45 seconds 
                 Final fill at 720С for 7 minutes. 
t, 0С - the annealing temperature of specific primers.
The sequences of the primers used in this work were 
selected based on the nucleotide sequences of the DNA 
fragments  analyzed  that  were  available  in  the  GenBank 
database. The next step in the DNA-diagnostics following 
the PCR was the restriction analysis (this was performed 
in a separate room). After centrifugation in a Vortex 
microcentrifuge for 3-10 seconds, 5-10μl of the amplificate 
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was transferred using individual tips from mineral oil into 
new, pre-labeled test tubes.
The results of the amplification were analyzed by vertical 
electrophoresis in polyacrylamide gel, followed by staining 
the gel with ethidium bromide solution and registration in UV 
of 312 nm.
A  7%  gel  in  a  29  to  1  ratio  of  acrylamide  to  bis-
acrylamide was used for the analysis of the electrophoretic 
mobility  of  the  fragments  of  amplification.  Ammonium 
persulfate and TEMED were the catalysts used to polymerize 
the gel. Electrophoresis was performed in 1 x TBE buffer (89 
mM Tris-borate, 89 mM boric acid, 2 mM EDTA) in an electric 
field intensity of 16 V/cm at room temperature. The samples 
were mixed with the stain (0.5% bromophenol blue and 0.5% 
xylene cyanol) in a ratio of 5:1 prior to gel application for 
clear visual inspection.
Statistical analysis was performed using the statistical 
computer  program  SPSS  (version  10.0.7)  and  «Statistica» 
(version 6.0) for Windows. A value of P<0.05 was considered 
statistically significant.
Results 
Clinical characteristics of the patients
The  women  examined  ranged  in  age  from  23  to  39 
(30.2±0.4) years. The entire group of females was concerned 
with  infertility.  Among  them  59  (65.5%)  had  primary 
infertility  while  31  (34.5%)  had  secondary  infertility.  The 
average duration of infertility in the primary infertility female 
patients was 3.6±0.7 years, whereas those with the secondary 
type showed 3.2±1.3 years, revealing no significant difference 
between both groups.
Analysis of the reproductive anamnesis revealed that the 
first group included 9 (26.5%) patients with primary infertility 
and 25 (73.5%) with secondary, whereas the second group 
had 34 (64.3%) patients with primary and 22 (35.7%) with 
secondary. The frequency of pregnancy before secondary 
infertility in both patient groups is as follows: labor – 4 
(8.5%) patients, medical abortions -11 (23.4%), spontaneous 
abortions – 16 (34.0%), medical and spontaneous abortions – 
2 (4.3%).
On analysis of their gynecological status it was evident 
that the alvus during bimanual examination corresponded to 
normal size in both patient groups, and no pathological changes 
on the uterine appendages were revealed. On palpation of the 
area of the patients’ uterosacral ligaments and the posterior 
vaginal fornix, there was evidence of their shortening and 
compaction, as well as soreness expressed during the study.
All the patients examined were of requisite physique and their 
physical development was consistent with the age norm.
In one-half of the cases, both the first and the second 
patient groups had digestive disorders (chronic gastritis, peptic 
ulcer disease). The second group in anamnesis had three times 
more often indications of respiratory diseases. Also, these 
patients showed an increase in the frequency of the pustular 
skin lesions and neurodermatitis (by two times compared 
with the group of women who became pregnant). Perhaps this 
was due to the endogenous intoxication and changes in the 
antioxidant status, although in the immune system this is due 
to a violation of the xenobiotic or drug metabolism [9,10].
Burdened family anamnesis was recorded in 12 (35.3%) 
patients of the first group and 41 (73.2%) of the second. Among 
them, in the first group, it was due to oncological diseases in 
2 (16.7%) patients, due to respiratory diseases in 3 (25.0%) 
patients, and as a result of diseases of the cardiovascular 
system in 6 (50.0%) and diabetes in one (8.3%) of them. In 
the second group: due to oncological diseases in 9 (21.9%) 
patients, respiratory disease in 21 (51.2%) patients, diseases of 
the cardiovascular system in 9 (21.9%) patients and diabetes 
in 3 (7.3%). Therefore, patients of the second group in the 
anamnesis had 1.5 times more frequent cases of cancer and 
had two times more diseases of the respiratory system in the 
immediate family of the first and second lines of relatedness. 
Compared with the first group, they had two times less number 
of recorded instances of cardiovascular system diseases.
The second group included 49 (87.5%) patients who had 
aggravated allergic anamnesis, viz., of these 19 (38.7%) had 
allergy to drugs, 16 (32.7%) had allergy to household chemicals 
whereas  14  (28.6%)  had  it  to  certain  foods.  Aggravated 
allergic anamnesis was also present in four (11.8%) patients 
of the first group.
Family gynecological anamnesis was aggravated in 18 
(52.9%) patients of the first group and in 43 (76.8%) patients 
of the second group. Among them 10 (55.6%) patients and 29 
(67.4%) patients had endometriosis (adenomyosis, peritoneal 
endometriosis or endometrial ovarian cysts), 6 (33.3%) and 9 
(20.9%) patients had hysteromyoma, 2(11.1%) and 5 (11.6%) 
of them had a pathology of the endometrium. Therefore, the 
family gynecological anamnesis of the pregnant women in 
the first group was not significantly different from that of the 
second group.
No  evidence  of  significant  differences  was  observed 
between the stages of endometriosis in both groups. 
Among them 52 % of the pregnant patients had stages I – II 
endometriosis, 48% had stage III-IV, whereas in the group 
of  non-pregnant  patients  the  figures  were  45%  and  55%, 
respectively. The prevalence and incidence of an adhesive 
process in the pelvis was also not different in both groups.
Features of the NAT2 gene polymorphism
75.6%  of  the  female  patients  with  infertility  and 
peritoneal endometriosis, who participated in this study, 
had point mutations in the NAT2 gene (NAT2*5: c.341T>C, 
c.481C>T,  c.803A>G  and  NAT2*6:  c.590G>A),  which 
exceeded the average rates in the population. Mutation of 
NAT2*7 (c.857G>A) were not identified (Table 1).
Table 1 
Incidence of the NAT2 gene point mutations in comparison with 
literature data
Allele Research results Literature data*
(degree of incidence) Abs. Frequency 
Т341С 68 0.756 0.227-0.458
С481T 55 0.611 0.388-0.442
G590A 11 0.122 0.268-0.317
A803G 67 0.744 0.395-0.428
G857A 0 0 0.020-0.034
Note: * - Lin et al., 1994[20]; Brockmoller et al., 1996[21]; 
Woolhouse et al., 1997 [22]; Gross et al., 1999 [23]; Anitha, 
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The degrees of incidence of the point mutations 
с.341Т>C,  c.481C>T,  c590G>A  and  c.803A>G  were 
compared with respect to the stage of endometriosis (EM) and 
no significant differences were observed (Table 2).
 It is important to note that the presence of the 
heterozygous  mutation  variants  NAT2*5A  (c.341T>C, 
c.481C>T), NAT2*5B (c.341T>C, c.481C>T and c.803A>G), 
NAT2*5C (c.341T>C, c.803A>G) in stage I-II endometriosis 
was significantly higher than the presence of the homozygous 
mutation variants, although in stage III-IV both variants were 
present equally. Furthermore, the homozygous type of point 
mutation of NAT2*6B (c590G>A) in stage III-IV is higher than 
that of the heterozygous type. Data evaluation on the hetero-
and homozygous point mutations depending on the stage of 
endometriosis revealed significant differences (Table 3). 
On analyzing the combinations of the mutations, it was 
been found that in stage III-IV endometriosis the frequency 
of three and more point substitutions is significantly higher 
(Table 4).
Analysis of the NAT2 gene polymorphisms in (Table 
5) showed that the first group (those who became pregnant) 
mostly included patients without the mutations which create 
the “slow” allelic variants of the NAT2 gene. In the patient 
group which did not become pregnant after treatment, the 
presence of the heterozygous variant of the point substitutions 
341T>C, 481C>T, c.590G>A and c.803A>G was 73.2, 73.2, 
5.4 and 62.5 %, respectively (P<0.05). 
The  frequency  of  the  homozygous  variant  differed 
significantly only in the case of c.590G>A mutation. In the 
patient group which included those who did not become 
pregnant,  this  frequency  was  12.5%,  while  patients  who 
became pregnant did not have this mutation at all (P< 0.05).
Discussion
According  to  the  specialized  literature,  infertility  in 
every fourth woman is combined with endometriosis [11,12]. 
Therefore, it should be also noted that the patients having 
received surgical treatment of the peritoneal endometriosis 
became pregnant 1.5 times more frequently than those patients 
who received conservative treatment [13]. In this study, the 
NAT2 gene polymorphism was identified in 68 (75.6%) of 
all the patients with peritoneal endometriosis and infertility: 
NAT2*6B  (c590G>A)  in  15  (22.3%)  patients,  NAT2*5A 
(c.341T>C, c.481C>T) or NAT2*5C (c.341T>C, c.803A>G) 
in  27  (39.7  %)  patients,  NAT2*5B  (c.341T>C, c.481C>T 
and c.803A>G) or combination NAT2*5 and NAT2*6 in 26 
(38.2 %) patients.  Studies examining the inter-relationship 
of the number of point mutations in the NAT2 gene and the 
Table 2 
Distribution of point mutations at different stages of endometriosis
Stage of EM
Point mutation
с.341Т>C
 (n=68)
c.481C>T
(n=55)
c.803A>G 
(n=67)
c.590G>A
(n=11)
n % n % n % n %
I 15 22.1 11 20.0 17 25.4 2 18.2
II 16 23.5 13 23.6 15 22.4 3 27.2
III 22 32.4 16 29.1 17 25.4 3 27.3
IV 25 36.7 15 27.3 18 26.8 3 27.3
р > 0.05 > 0.05 > 0.05 > 0.05
Table 3 
The frequency of hetero- and homozygous point mutation variants 
depending on the stage of endometriosis
Stage of
 EM
с.341Т>C
       (n=68)
c.481C>T 
       (n=55)
c.803A>G
       (n=67)
c590G>A
       (n=11) р
СТ СС CT TT AG GG GA AA
I-II n 36 4 43 1 33 5 3* 2* <0.05
% 52.9 5.9 78.1 1.8 49.3 7.4 27.3 18.2
III-IV n 18 10 6 5 12 17 1 5 >0.05
% 26.5 14.7 10.9 9.2 17.9 25.4 9.1** 45.4**
p <0.05<0.05 <0.05 <0.05 <0.05 <0.05 <0.05 <0.05
* - p>0.05; ** - p<0.05. 
Table 4 
The frequency of different combinations of point mutations at 
various stages of endometriosis 
Stage of
EM
Combinations of discovered point mutations
1-2 (n=42) 
NAT2*5A/NAT2*5C/
NAT2*6B
3 and more (n=26)
NAT2*5B/NAT2*5C/
NAT2*6B
n % n %
I-II 34 80.9 3 11.5
III-IV 8 19.1 23 88.5
p < 0.05 < 0.05
Table 5 
The distribution of different variants of point mutations in the 
NAT2 gene among women of the Group 1 and Group 2
Genotypes
Group 1 Group 2
р n=34 n=56
n % n %
  с.341 Т>C
  ТТ 16 47.1 6 10.7 < 0.05
  СТ 13 38.2 41 73.2 < 0.05
СС 5 14.7 9 16.1 > 0.05
c.481 C>T
CC 24 70.6 11 19.6 < 0.05
CT 8 23.5 41 73.2 < 0.05
TT 2 5.9 4 7.2 > 0.05
c590 G>A
GG 33 97.1 46 82.1 > 0.05
GA 1 2.9 3 5.4 > 0.05
AA 0 0 7 12.5 < 0.05
c.803 A>G
AA 18 52.9 5 8.9 < 0.05
AG 10 29.5 35 62.5 < 0.05
GG 6 17.6 16 28.6 > 0.05
c.857 G>A
GG 23 100 37 100 > 0.05
GA 0 0 0 0 0
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pregnancy frequency in patients with gynecological diseases 
are not available in the literature.
It has been proven that the allelic variants of the 
NAT2 gene are characterized by the different activity of the 
N-acetyltransferase enzyme. Based on this factor, the carriers 
of the respective allelic variants are distinguished as ‘fast’, 
‘intermediate’ and ‘slow’ acetylators [14]. Experimental point 
mutations (NAT2*5  and NAT2*6) lead to the development 
of the ‘slow acetylation phenotype’, which, according 
to the literature, help to reduce the level of the enzyme N- 
acetyltransferase, thus slowing down the conversion of the 
acetyl-CoA  to  acetoacetyl-CoA  [15].  The  metabolism  of 
xenobiotics is disturbed during such changes and this increases 
the level of endogenous intoxication.
Data available in the literature states that the changes 
in the activity of the enzymes that metabolize the xenobiotics 
enhance the risk of cancer. This is due to the bioactivation 
of a large number of procarcinogens and a disruption of the 
detoxification process of the external oncogenic substances. 
Thus, it is concluded that the genetic factors, detoxification 
system  and  oxidative  stress  play  definite  roles  in  the  case 
of endometriosis and infertility [17]. It is also interesting to 
note that the disruptions in the estrogen metabolism in the 
endometrium in the case of endometriosis, which is a result 
of an imbalance of the detoxification phases I and II , lead 
to the build-up of the free radicals and a stimulation of the 
proliferation of the ectopic endometrium [18]. It is possible 
that these changes, conditional on the genetic polymorphism 
of  the  detoxification  genes,  are  an  additional  factor  for 
uterine infertility among the patients with endometriosis. 
The relationship between genetic polymorphism and male 
infertility is proven, although the precise mechanisms are yet 
to be studied [19].
Thus, in summary,
•  As a result of this study, the point mutations that create 
the “slow” allelic variants of the NAT2 gene were identified in 
75.6% of patients with infertility and peritoneal endometriosis, 
which is almost 1.5 times higher than the average statistical 
rate in Russia.
•  No significant differences were observed in patients 
with the NAT2 gene polymorphism depending on the 
stage of endometriosis; however, the relationship between 
the  frequency  of  the  homozygous  variants  of  the  point 
substitutions, the number of mutation combinations and the 
stage of endometriosis were recorded. The presence of the 
heterozygous  point  substitutions  c.341T>C,  c.481C>T  and 
c.803A>G was significantly higher in the case of stages I-II 
endometriosis than in its common forms.
•    The  patients  with  peritoneal  endometriosis,  who 
became pregnant due to the treatment, had three times 
lower degree of incidence of the “slow” allelic variant of 
the polymorphism in the NAT2 gene (NAT2*5: c.341T>C, 
c.481C>T  and  c.803A>G; NAT2*6:  c.590G>A)  than  those 
who did not become pregnant.
•  Certain features of the in NAT2 gene polymorphisms 
(‘acetylation phenotype’) are associated with the effectiveness 
of the infertility treatment in women with peritoneal 
endometriosis. Patients without the point mutations, which 
create “slow” allelic variants of the NAT2 gene, can be 
considered the group with the favorable prognosis.
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